Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:45:52 +0200Thu, 20 Jun 2024 15:48:00 +0200Human medicines European public assessment report (EPAR): Luxturna, voretigene neparvovec, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/luxturnaHuman medicines European public assessment report (EPAR): Luxturna, voretigene neparvovec, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/luxturnaThu, 20 Jun 2024 15:48:00 +0200Human medicineLuxturna : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-4451-par_en.pdfLuxturna : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/h-4451-par_en.pdfFri, 11 Jan 2019 12:01:00 +0100Human medicine